Endocrine disruptors (EDs) and hormone-dependent cancers: Correlation or causal relationship?

Rochefort, 2008, Cancérogenèse hormonale chez la femme : des mécanismes à la prévention, C R Biologies, 331, 104, 10.1016/j.crvi.2006.07.009 Belot, 2008, Cancer incidence and mortality in France over the period 1980–2005, Rev. Epidemiol. Sante Publique, 56, 159, 10.1016/j.respe.2008.03.117 Binder-Foucard, 2013 Ferlay, 2007, Estimates of the cancer incidence in Europe in 2006, Ann. Oncol., 18, 581, 10.1093/annonc/mdl498 Rochefort, 2003, Les traitements hormonaux substitutifs (TSH) de la ménopause : évolution récente du rapport bénéfices/risques, Bull. Acad. Natl. Med., 187, 1707 Ravdin, 2007, The decrease of breast cancer incidence in 2003 in the USA, N. Engl. J. Med., 356, 1670, 10.1056/NEJMsr070105 Ikeda, 1982, Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture, In Vitro, 18, 961, 10.1007/BF02796371 Soto, 1992, A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I), J. Steroid Biochem. Mol. Biol., 43, 703, 10.1016/0960-0760(92)90296-U Chalbos, 1982, Estrogens stimulate cell proloiferation and induce secretory proteins in a human breast cancer cell line (T47D), J. Clin. Endocrinol. Metab., 55, 276, 10.1210/jcem-55-2-276 Lippman, 1976, The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term culture, Cancer Res., 36, 4595 Krishnan, 1993, Bisphenol A: an estrogenic substance is released from polycarbonate flasks during autoclaving, Endocrinology, 132, 2279, 10.1210/endo.132.6.8504731 Snedeker, 2001, Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin, Environ. Health Perspect., 109, 35, 10.1289/ehp.01109s135 Boffetta, 2010, An estimate of cancers attributable to occupational exposures in France, J. Occup. Environ. Med., 52, 399, 10.1097/JOM.0b013e3181d5e355 Cohn, 2011, Development and environmental origins of breast cancer, Reprod. Toxicol., 31, 302, 10.1016/j.reprotox.2010.10.004 Cohn, 2015, DDT exposure in utero and breast cancer, J. Clin. Endocrinol. Metab., 100, 2865, 10.1210/jc.2015-1841 Fenton, 2015, Timing of environmental exposures as a critical element in breast cancer risk, J. Clin. Endocrinol. Metab., 100, 3245, 10.1210/jc.2015-2848 Ho, 2015, Mortality of breast cancer in Taiwan, 1971–2010: temporal changes and an age-period-cohort analysis, J. Obstet. Gynaecol., 35, 60, 10.3109/01443615.2014.935717 Steenland, 2004, Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen, Environ. Health Perspect., 112, 1265, 10.1289/ehp.7219 Herbst, 1971, Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women, N. Engl. J. Med., 284, 878, 10.1056/NEJM197104222841604 Couse, 2001, Estrogen receptor-α knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract, Dev. Biol., 238, 224, 10.1006/dbio.2001.0413 Rubin, 2011, Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects, J. Steroid Biochem. Mol. Biol., 127, 27, 10.1016/j.jsbmb.2011.05.002 Vom Saal, 2007, Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure, Reprod. Toxicol., 24, 131, 10.1016/j.reprotox.2007.07.005 Diamanti-Kandarakis, 2009, Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr. Rev., 30, 293, 10.1210/er.2009-0002 Zoeller, 2012, Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society, Endocrinology, 153, 4097, 10.1210/en.2012-1422 Rochefort, 2011, Rapport complet de l’Académie de médecine sur perturbateurs endocriniens, www.academie-medecine.fr. Endocrine disruptors and hormone-dependent cancers, Bull. Acad. Natl. Med., 195, 1965 Mandrup, 2016, Low-dose effects of bisphenol A on mammary gland development, Andrology, 4, 673, 10.1111/andr.12193 Jenkins, 2011, Chronic oral exposure to bisphenol A results in a non-monotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice, Environ. Health Perspect., 119, 1604, 10.1289/ehp.1103850 Vandenberg, 2008, Perinatal exposure to the xenoestrogen bisphenol A induces mammary intraductal hyperplasias in adult CD-1 mice, Reprod. Toxicol., 26, 210, 10.1016/j.reprotox.2008.09.015 Durando, 2007, Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats, Environ. Health Perspect., 115, 80, 10.1289/ehp.9282 N’Tumba-Byn, 2012, Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal Leydig cell function, PloS One, 7, e51579, 10.1371/journal.pone.0051579 Dolinoy, 2007, Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development, Proc. Natl. Acad. Sci. U S A, 104, 13056, 10.1073/pnas.0703739104 Prins, 2008, Endocrine disruptors and prostate cancer risk, Endocr. Relat. Cancer, 15, 649, 10.1677/ERC-08-0043 Rochefort, 2008, Comment réduire l’incidence des cancers du sein, Bull. Acad. Natl. Med., 192, 161 Kortenkamp, 2007, Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals, Environ. Health Perspect., 115, 98, 10.1289/ehp.9357 Myers, 2016, Concerns over use of glyphosate-based herbicides and risks associated with exposures: a consensus statement, Environ. Health., 15, 19, 10.1186/s12940-016-0117-0 Russo, 2016, Understanding genistein in cancer: the “good” and the “bad” effects: a review, Food Chem., 196, 589, 10.1016/j.foodchem.2015.09.085